Search Results for: 340B

Uncategorized

Sixteenth Street Meets Patient Needs with the Help of 340B

This post is part of NACHC’s 340B Blog Series. The 340B Drug Pricing Program is an essential source of support for Community Health Centers, allowing them to stretch increasingly scarce federal resources and reinvest in patient care. Learn more about 340B and read other blogs in the series. Elizabeth Linderbaum is NACHC’s Deputy Director of Regulatory Affairs. Sixteenth …

Uncategorized

Giving Thanks to the 340B Drug Pricing Program Our Patients Rely On

Author: Sue Veer, MBA, president and CEO of Carolina Health Centers and NACHC Board Secretary. Right before Thanksgiving, Community Health Centers across the country held a Zoom Rally and Twitter Storm using the hashtag #340BThankful. During Thanksgiving week, the #340BThankful hashtag was used 305 times and garnered a whopping 120,826 impressions!  Twitter is perhaps the …

Health Center Advocacy, Uncategorized

NACHC Leads Advocacy Efforts to Ensure 30 More Years of 340B

Friday, November 4th marks 30 years since Congress passed legislation codifying the 340B Drug Pricing Program in 1992, naming it after a section of the Public Health Service Act. The 340B Drug Pricing Program was created to assist safety-net providers, like Community Health Centers, “to stretch scarce Federal resources as far as possible, reaching more …

Health Center Advocacy, Health Center Federal Policy, Health Center News, Health Center Regulatory Issues, Uncategorized

340B Spotlight: How 340B Savings Supports Innovation at Carolina Health Centers

Without 340B savings, the health center’s many services that expand access to care — like free prescription deliveries — would be in jeopardy of being rolled back or discontinued.

Health Care News, Health Center Advocacy, Health Center Federal Policy, Health Center Regulatory Issues, Uncategorized

Defending the 340B Program from Every Direction

The 340B Drug Pricing Program has weathered attacks from different health care actors for years. Just months after the outbreak of the COVID-19 pandemic, manufacturers launched attacks by refusing to sell 340B-priced drugs to health centers that use contract pharmacies to increase patient access. This combination of manufacturer restrictions, alongside existing discriminatory contracting actions taken …

Health Care News, Health Center News, Uncategorized

Why Protecting 340B Matters

The 340B Drug Pricing Program makes it possible for Community Health Center patients to afford life-saving medications and is an an essential source of support for health centers to stretch increasingly scarce federal resources and reinvest in patient care. Over the course of the past few years, while health centers have been fighting COVID-19, the program …

Uncategorized

Speaking Out in Defense of the 340B Drug Discount Program

Community Health Centers are on the frontlines of the pandemic providing comprehensive care and helping prevent emergency rooms from becoming overwhelmed. Yet, recent actions by some drug companies threaten a federal drug discount program called 340B that is critical to health centers. Health centers, primary care associations, and pharmacists joined a recent Twitter chat co-hosted …

Health Center Federal Policy, Health Center Regulatory Issues

House Subcommittee Focuses on the 340B Program

While other health care related issues have certainly taken up much of the space on Congress’ agenda over the past year, the 340B program can be added to the list of issues at which Congress has taken a closer look at over the past several months.  A case in point is the House Energy and Commerce …